$NAMS

$23.20▲ -3.9% YTD

6 SEC 13D/G filings tracked · Last updated Oct 2, 2026

Filing History

News

NAMS ▼ -3.9% - NewAmsterdam Pharma Company N.V.

CP $23.20▲ -3.9%Oct 2, 2026 · ThinkSabio Blog

$NAMS NAMSW - NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)…

News

NAMS ▲ +0.6% - NewAmsterdam Pharma Company N.V.

CP $23.71▲ +0.6%Sep 29, 2026 · ThinkSabio Blog

$NAMS NAMSW - NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial Evaluating Obicetrapib in Preclinical Alzheimer’s Disease…

SEC 13D/G

NAMS - NewAmsterdam Pharma Company N.V. - SEC Filing Update (22-SEP-2026) | ThinkSabio - Stocks Simplified

$24.20▼ -31.15%Sep 22, 2026 · ThinkSabio Blog

$NAMS SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #NAMS NewAmsterdam Pharma Company N.V. : $24.20 Sector: Healthca…

News

NAMS ▲ +0.7% - NewAmsterdam Pharma Company N.V.

CP $22.65▲ +0.7%Sep 21, 2026 · ThinkSabio Blog

$NAMS NAMSW - NewAmsterdam Pharma and Menarini Group Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetra…

News

NAMS ▲ +0.9% - NewAmsterdam Pharma Company N.V.

CP $25.83▲ +0.9%Sep 3, 2026 · ThinkSabio Blog

$NAMS NAMSW - NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)…

SEC 13D/G

NAMS - NewAmsterdam Pharma Company N.V. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks Simplified

$27.87▼ -20.71%Aug 6, 2026 · ThinkSabio Blog

$NAMS SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #NAMS NewAmsterdam Pharma Company N.V. : $27.87 Sector: Healthca…